Manulife (Manufacturers Life Insurance)’s Northwest Biotherapeutics, Inc. Common stock NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,431
Closed -$1K 4603
2016
Q3
$1K Hold
2,431
﹤0.01% 4273
2016
Q2
$1K Sell
2,431
-32,067
-93% -$34.2K ﹤0.01% 4236
2016
Q1
$50K Buy
34,498
+1,617
+5% +$3.19K ﹤0.01% 3291
2015
Q4
$105 Hold
32,881
﹤0.01% 3077
2015
Q3
$206 Buy
32,881
+540
+2% +$5.05K ﹤0.01% 2635
2015
Q2
$321 Buy
32,341
+3,792
+13% +$33.2K ﹤0.01% 2460
2015
Q1
$210 Buy
28,549
+61
+0.2% +$410 ﹤0.01% 2698
2014
Q4
$153 Buy
28,488
+3,532
+14% +$18.1K ﹤0.01% 2842
2014
Q3
$126 Buy
24,956
+680
+3% +$4.18K ﹤0.01% 2968
2014
Q2
$163K Buy
24,276
+23,006
+1,811% +$146K ﹤0.01% 2883
2014
Q1
$9 Hold
1,270
﹤0.01% 3393
2013
Q4
$5 Hold
1,270
﹤0.01% 3557
2013
Q3
$4 Sell
1,270
-329
-21% -$1.15K ﹤0.01% 3452
2013
Q2
$5K Buy
+1,599
New +$5.8K ﹤0.01% 3298

Other funds holding NWBO

Manulife (Manufacturers Life Insurance)'s NWBO Position: Q4 2016 in Review

Manulife (Manufacturers Life Insurance) sold out of Northwest Biotherapeutics, Inc. Common stock (NWBO) in Q4 2016, closing a stake of 2,431 shares — an estimated $1K sold.

Manulife (Manufacturers Life Insurance) first reported a position in NWBO in Q2 2013 and held it in 14 quarters. The position peaked at $163K in Q2 2014. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Manulife (Manufacturers Life Insurance) reported no remaining Northwest Biotherapeutics, Inc. Common stock position as of Q4 2016 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 2,431 Northwest Biotherapeutics, Inc. Common stock shares in Q4 2016, an estimated $1K.
  • Manulife (Manufacturers Life Insurance) first reported a position in Northwest Biotherapeutics, Inc. Common stock in Q2 2013 and held it in 14 quarters.
  • Manulife (Manufacturers Life Insurance)'s Northwest Biotherapeutics, Inc. Common stock position peaked at $163K in Q2 2014.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics, Inc. Common stock as of Q4 2016.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2016, filed 14 Feb 2017.